Logo-apb
Adv Pharm Bull. 2017;7(2): 275-279. doi: 10.15171/apb.2017.033
PMID: 28761830        PMCID: PMC5527242

Research Article

Studying the Effect of Sertraline in Reducing Aggressive Behavior in Patients with Major Depression

Alireza Farnam 1, Arezoo MehrAra 1, Hossein Dadashzadeh 1, Golamreza Chalabianlou 1, Salman Safikhanlou 1 *

Cited by CrossRef: 8


1- Fu R, Hao X, Yu J, Wang D, Zhang J, Yu Z, Gao F, Zhou C. Machine learning-based prediction of sertraline concentration in patients with depression through therapeutic drug monitoring. Front Pharmacol. 2024;15 [Crossref]
2- Halaris A, Sayed A, Hakimi M, Sinacore J. Modulation of the inflammatory response exerts beneficial effects on anger in treatment-resistant bipolar depression. Journal of Affective Disorders Reports. 2023;13:100602 [Crossref]
3- Lee S, Yoo J, Seo S, Lee J, Kim G, Cho E. The Mental Health Outcomes and Cost Estimates of Korean Medicine for Anxiety Disorder Patients. Healthcare. 2024;12(13):1345 [Crossref]
4- Yang L, Zhang J, Yu J, Yu Z, Hao X, Gao F, Zhou C. Predicting plasma concentration of quetiapine in patients with depression using machine learning techniques based on real-world evidence. Expert Review of Clinical Pharmacology. 2023;16(8):741 [Crossref]
5- Simutkin G. Anger attacks and «anger disorders»: clinical relevance, problem of classification, comorbidity and therapy (review). VM BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2018;(3):10 [Crossref]
6- Romero-Martínez Á, Murciano-Martí S, Moya-Albiol L. Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review. Behavioral Sciences. 2019;9(5):57 [Crossref]
7- Kwon C, Suh H, Kim J, Chung S. Anti-anger Effects of Herbal Medicine: A Mini-Review of Rat Studies. Chin J Integr Med. 2022;28(3):263 [Crossref]
8- Yao X, Li Y, Yu Z, Mo C, Pan H, Li C. The efficacy and safety of agomelatine, sertraline, and escitalopram for senile post-stroke depression: A randomized double-blind placebo-controlled trial. Clinical Neurology and Neurosurgery. 2021;205:106651 [Crossref]